ARB-001467

· Arbutus Biopharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARB-001467, covering 2018-06-29 to 2018-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy [Phase 2]